Kendle confirms Latin American deal

By staff reporter

- Last updated on GMT

Related tags: Latin america, Brazil

Kendle, who has been expanding its reach across the globe,
targeting the emerging Asia Pacific and Latin American markets, has
announced the acquisition of Latin American-based contract research
organisation, International Clinical Research.

The deal adds new operations in Argentina, Brazil, Colombia and Chile to Kendle's Phase II-IV clinical development capabilities.

Kendle already has operations in Mexico and Peru, and recently reorganised its global business into five regions made up of North America, Europe, Asia/Pacific, Latin America and Africa.

The acquisition, expected to be completed in the second quarter, is the culmination of an ongoing relationship between the two companies, who have worked together in recent years on drug development programs in Latin America.

Kendle will acquire the company for an undisclosed cash amount although specific terms of the agreement were not disclosed. It is expected to be modestly accretive to earnings in 2006 and will operate under the Kendle name.

"We believe this merger will provide great benefit to the development of clinical research in Latin America,"​ said Raul Bozzo, founder of International Clinical Research.

"Kendle's reach will bring a wider variety of trials to the region, and our specialised staff and country-specific expertise will add value to Kendle's Latin American operations," he said.

Related news

Show more

Related products

show more

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Formedix | 20-Jun-2022 | Technical / White Paper

This article explains the different types of clinical trial software available, and how it can be used to optimize the end to end clinical trials design...

Strategic Approach to Immunogenicity Assessment

Strategic Approach to Immunogenicity Assessment

Altasciences | 17-May-2022 | Technical / White Paper

In this issue of The Altascientist we provide a detailed overview on the different goals and challenges that are presented by the validation of immunogenicity...

Governing and Maintaining Clinical Data Standards

Governing and Maintaining Clinical Data Standards

Veeva | 10-May-2022 | Technical / White Paper

Investing in data standards plays a huge role in improving the quality of clinical studies. But often, people don’t use the standards correctly, there...

What the Best Clinical Study Build Pros Do

What the Best Clinical Study Build Pros Do

Formedix | 09-May-2022 | Technical / White Paper

Getting your clinical study designed and built ready for data collection takes A LOT of work and expertise… you've got to do all your CRF designs;...

Related suppliers

Follow us


View more